Analysis of proximalALOX5promoter binding proteins by quantitative proteomics
Open Access
- 1 October 2020
- journal article
- research article
- Published by Wiley in The FEBS Journal
- Vol. 287 (20), 4481-4499
- https://doi.org/10.1111/febs.15259
Abstract
5-Lipoxygenase (5-LO) is the initial enzyme in the biosynthesis of leukotrienes, which are mediators involved in pathophysiological conditions such as asthma and certain cancer types. Knowledge of proteins involved in 5-LO pathway regulation, including gene regulatory proteins, is needed to evaluate all options for therapeutic intervention in these diseases. Here, we present a mass spectrometric screening ofALOX5promoter-interacting proteins, obtained by DNA pulldown and label-free quantitative mass spectrometry. Protein preparations from myeloid and B-lymphocytic cell lines were screened for promoter DNA interactors. Through statistical analysis, 66 proteins were identified as specificALOX5promotor binding proteins. Among those, the 15 most likely candidates for a prominent role inALOX5gene regulation are the knownALOX5interactors Sp1 and Sp3, the related factor Sp2, two Kruppel-like factors (KLF13 and KLF16) and six other zinc finger proteins (MAZ, PRDM10, VEZF1, ZBTB7A, ZNF281 and ZNF579). Intriguingly, we also identified two helicases (BLM and DHX36) and the proteins hnRNPD and hnRNPK, which are, together with the protein MAZ, known to interact with DNA G-quadruplex structures. As G-quadruplexes are implicated in gene regulation, spectroscopic and antibody-based methods were used to confirm their presence within the GC-rich sequence of theALOX5promoter. In summary, we have systematically characterized the interactome of theALOX5promoter, identifying several zinc finger proteins as novel potentialALOX5gene regulators. Further, we have shown that theALOX5promoter can form DNA G-quadruplex structures, which may play a functional role inALOX5gene regulation.This publication has 71 references indexed in Scilit:
- Neutrophils support lung colonization of metastasis-initiating breast cancer cellsNature, 2015
- 5-Lipoxygenase, a key enzyme for leukotriene biosynthesis in health and diseaseBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2015
- 5-Lipoxygenase Is a Direct Target of miR-19a-3p and miR-125b-5pThe Journal of Immunology, 2015
- Recent Advances in the Search for Novel 5‐Lipoxygenase InhibitorsBasic & Clinical Pharmacology & Toxicology, 2013
- The Leukotrienes: Immune-Modulating Lipid Mediators of DiseasePublished by Elsevier BV ,2012
- Overexpression of 5-Lipoxygenase in Colon Polyps and Cancer and the Effect of 5-LOX Inhibitors In vitro and in a Murine ModelClinical Cancer Research, 2008
- 5-Lipoxygenase: regulation of expression and enzyme activityTrends in Biochemical Sciences, 2007
- Overexpression of 5-Lipoxygenase and Cyclooxygenase 2 in Hamster and Human Oral Cancer and Chemopreventive Effects of Zileuton and CelecoxibClinical Cancer Research, 2005
- Increased 5-lipoxygenase expression and induction of apoptosis by its inhibitors in esophageal cancer: a potential target for preventionCarcinogenesis: Integrative Cancer Research, 2005
- A comparative study on the expression of cyclooxygenase and 5-lipoxygenase during cerebral ischemia in humansActa Neuropathologica, 2002